Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3600/- USD | Published Date: May 3, 2021 |

The global single nucleotide polymorphism genotyping market size is accounted to register a significant CAGR of 21% during the forecast period 2021 to 2027. The rising prevalence of fatal incidences such as diabetes, cancer, and others is a major factor driving the market growth. The rising demand for genetic analysis in plants and animals is further expected to drive the market. Moreover, the presence of private and public funds programs in the field of genetics, reducing the cost of sequencing, the introduction of innovative technologies, and growing demand from clinical research. In addition, the technological advancement such as the increasing use of mass arrays systems and use of real-time and multiplex PCR is further expected to propel the market.

Market Segment Insights:

The global single nucleotide polymorphism genotyping market is bifurcated into technology, application, and geography. On the basis of technology, the market is further segmented into SNP Genechips and Microarrays, TaqMan Assay, RFLP, SSCP, ARMS, and other SNP Genotyping Technologies. By application, the market is divided into animal genetics, plant improvement, diagnostic research, aquaculture, pharmaceuticals and pharmacogenomics, agricultural biotechnology, animal livestock and breeding, and others.

Single Nucleotide Polymorphism Genotyping Market Size

To know more about the study, request a report sample

The single nucleotide polymorphism genotyping comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2020 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market, and expert opinion obtained from interviews with industry executives and experts from prominent companies.

Global single nucleotide polymorphism genotyping market size and forecast was obtained by using “Bottom-up” and “Top-down” approaches. Extensive secondary research was conducted to understand the market insights and trends, followed by primary interviews to further validate the information sourced. The report provides both, qualitative and quantitative analyses of the market, the competitive landscape, and the preferred development strategies of key players which help to formulate competitive market strategies and make informed decisions.

The single nucleotide polymorphism genotyping market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

  • 2018-19 – Historical Year
  • 2020 – Base Year
  • 2021-2027 – Forecast Period

Global Single Nucleotide Polymorphism Genotyping Market Segmentation:

By Technology:

  • SNP Genechips and Microarrays
  • TaqMan Assay (Allelle-Specific Hybridization)
  • SNP Genotyping based upon Pyrosequencing
  • SN Plex based upon Applied Biosystems
  • Sequenom Masarray MALDI-TOF
  • RFLP (Restricted Fragment Length Polymorphism)
  • SSCP (Single-Strand Conformation Polymorphism)
  • ARMS (Amplication Refractory Mutation System)
  • Other SNP Genotyping Technologies

By Application:

  • Animal Genetics
  • Plant Improvement
  • Diagnostic Research
  • Aquaculture
  • Pharmaceuticals and Pharmacogenomics
  • Agricultural Biotechnology
  • Animal Livestock and Breeding
  • Other SNP applications

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographic Coverage:

Geographically, the single nucleotide polymorphism genotyping market report comprises dedicated sections centering on the regional market revenue and trends. The single nucleotide polymorphism genotyping market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, and Rest of the World (RoW). The RoW segment consists of Latin America and the Middle East & Africa. The single nucleotide polymorphism genotyping market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. Single nucleotide polymorphism genotyping market estimates have also been provided for the historical years 2018 & 2019 along with forecasts for the period from 2021 – 2027.

Market Competition Assessment:

Key players operating in the global single nucleotide polymorphism genotyping market are Sequenom, Inc., ThermoFisher Scientific, Life Technologies Corporation, PREMIER Biosoft, and Illumina, Inc. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

List of Key Companies:

  • Sequenom, Inc
  • ThermoFisher Scientific
  • Life Technologies Corporation
  • PREMIER Biosoft
  • Illumina, Inc.
  • Affymetrix, Inc.
  • Douglas Scientific LLC
  • Fluidigm
  • GENEWIZ
  • Eurofins Genomics

Key Questions Answered by Single Nucleotide Polymorphism Genotyping Market Report:

  • Global SNP genotyping market forecasts from 2021-2027
  • Regional SNP genotyping market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
  • SNP genotyping submarket forecasts from 2021-2027 covering the market by technology, by application, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis pertaining to SNP genotyping market
  • Analysis of the key factors driving and restraining the growth of the global, regional and country-level SNP genotyping markets from 2021-2027
  • Competitive Landscape and market positioning of top 10 players operating in the SNP genotyping market
Table of content:

1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

 

2. Executive Summary


2.1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Portraiture
2.2. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, by Technology, 2020 (USD Mn)
2.3. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, by Application, 2020 (USD Mn)
2.4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, by Geography, 2020 (USD Mn)

 

3. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Analysis


3.1. Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. COVID-19 Impact Analysis
3.6.1. V Shaped Recovery
3.6.2. U Shaped Recovery
3.6.3. L Shaped Recovery
3.6.4. W Shaped Recovery

 

4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market By Technology, 2018 – 2027 (USD Mn)


4.1. Overview
4.2. SNP Genechips and Microarrays
4.3. TaqMan Assay (Allelle-Specific Hybridization)
4.4. SNP Genotyping based upon Pyrosequencing
4.5. SN Plex based upon Applied Biosystems
4.6. Sequenom Masarray MALDI-TOF
4.7. RFLP (Restricted Fragment Length Polymorphism)
4.8. SSCP (Single-Strand Conformation Polymorphism)
4.9. ARMS (Amplication Refractory Mutation System)
4.10. Other SNP Genotyping Technologies

 

5. Global Single Nucleotide Polymorphism (SNP) Genotyping Market By Application, 2018 – 2027 (USD Mn)


5.1. Overview
5.2. Animal Genetics
5.3. Plant Improvement
5.4. Diagnostic Research
5.5. Aquaculture
5.6. Pharmaceuticals and Pharmacogenomics
5.7. Agricultural Biotechnology
5.8. Animal Livestock and Breeding
5.9. Other SNP applications

 

6. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Analysis and Forecast, 2018 – 2027 (USD Mn)


6.1.1. Overview
6.1.2. North America Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
6.1.3. North America Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)
6.1.4. North America Single Nucleotide Polymorphism (SNP) Genotyping Market by Country (2018-2027 USD Mn)
6.1.4.1. U.S.
6.1.4.1.1. U.S. Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
6.1.4.1.2. U.S. Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)
6.1.4.2. Canada
6.1.4.2.1. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
6.1.4.2.2. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)

 

7. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Analysis and Forecast, 2018 – 2027 (USD Mn)


7.1.1. Overview
7.1.2. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
7.1.3. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)
7.1.4. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market by Country (2018-2027 USD Mn)
7.1.4.1. Germany
7.1.4.1.1. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
7.1.4.1.2. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)
7.1.4.2. U.K.
7.1.4.2.1. U.K. Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
7.1.4.2.2. U.K. Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)
7.1.4.3. France
7.1.4.3.1. France Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
7.1.4.3.2. France Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)
7.1.4.4. Italy
7.1.4.4.1. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
7.1.4.4.2. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)
7.1.4.5. Rest of Europe
7.1.4.5.1. Rest of Europe Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
7.1.4.5.2. Rest of Europe Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)


8. Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Analysis and Forecast, 2018 – 2027 (USD Mn)


8.1.1. Overview
8.1.2. Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
8.1.3. Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)
8.1.4. Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market by Country (2018-2027 USD Mn)
8.1.4.1. China
8.1.4.1.1. China Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
8.1.4.1.2. China Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)
8.1.4.2. Japan
8.1.4.2.1. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
8.1.4.2.2. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)
8.1.4.3. Rest of Asia Pacific
8.1.4.3.1. Rest of Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
8.1.4.3.2. Rest of Asia Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)

 

9. Latin America (LATAM) Single Nucleotide Polymorphism (SNP) Genotyping Market Analysis and Forecast, 2018 – 2027 (USD Mn)


9.1.1. Overview
9.1.2. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
9.1.3. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)
9.1.4. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market by Country (2018-2027 USD Mn)
9.1.4.1. Brazil
9.1.4.1.1. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
9.1.4.1.2. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)
9.1.4.2. Mexico
9.1.4.2.1. Mexico Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
9.1.4.2.2. Mexico Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)
9.1.4.3. Rest of Latin America
9.1.4.3.1. Rest of Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
9.1.4.3.2. Rest of Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)

 

10. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Analysis and Forecast, 2018 – 2027 (USD Mn)


10.1.1. Overview
10.1.2. MEA Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
10.1.3. MEA Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)
10.1.4. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market, by Country (2018-2027 USD Mn)
10.1.4.1. GCC
10.1.4.1.1. GCC Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
10.1.4.1.2. GCC Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)
10.1.4.2. Rest of MEA
10.1.4.2.1. Rest of MEA Single Nucleotide Polymorphism (SNP) Genotyping Market by Technology (2018-2027 USD Mn)
10.1.4.2.2. Rest of MEA Single Nucleotide Polymorphism (SNP) Genotyping Market by Application (2018-2027 USD Mn)

 

11. Company Profiles


11.1. Sequenom, Inc.
11.1.1. Business Description
11.1.2. Financial Health and Budget Allocation
11.1.3. Product Positions/Portfolio
11.1.4. Recent Development
11.1.5. SWOT Analysis
11.2. ThermoFisher Scientific
11.2.1. Business Description
11.2.2. Financial Health and Budget Allocation
11.2.3. Product Positions/Portfolio
11.2.4. Recent Development
11.2.5. SWOT Analysis
11.3. Life Technologies Corporation
11.3.1. Business Description
11.3.2. Financial Health and Budget Allocation
11.3.3. Product Positions/Portfolio
11.3.4. Recent Development
11.3.5. SWOT Analysis
11.4. PREMIER Biosoft
11.4.1. Business Description
11.4.2. Financial Health and Budget Allocation
11.4.3. Product Positions/Portfolio
11.4.4. Recent Development
11.4.5. SWOT Analysis
11.5. Illumina, Inc.
11.5.1. Business Description
11.5.2. Financial Health and Budget Allocation
11.5.3. Product Positions/Portfolio
11.5.4. Recent Development
11.5.5. SWOT Analysis
11.6. Affymetrix, Inc.
11.6.1. Business Description
11.6.2. Financial Health and Budget Allocation
11.6.3. Product Positions/Portfolio
11.6.4. Recent Development
11.6.5. SWOT Analysis
11.7. Douglas Scientific LLC
11.7.1. Business Description
11.7.2. Financial Health and Budget Allocation
11.7.3. Product Positions/Portfolio
11.7.4. Recent Development
11.7.5. SWOT Analysis
11.8. Fluidigm
11.8.1. Business Description
11.8.2. Financial Health and Budget Allocation
11.8.3. Product Positions/Portfolio
11.8.4. Recent Development
11.8.5. SWOT Analysis
11.9. GENEWIZ
11.9.1. Business Description
11.9.2. Financial Health and Budget Allocation
11.9.3. Product Positions/Portfolio
11.9.4. Recent Development
11.9.5. SWOT Analysis
11.10. Eurofins Genomics
11.10.1. Business Description
11.10.2. Financial Health and Budget Allocation
11.10.3. Product Positions/Portfolio
11.10.4. Recent Development
11.10.5. SWOT Analysis
Fill the given form to inquiry before buying for Single Nucleotide Polymorphism (SNP) Genotyping Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample
Inquiry Before Buying


Select License Type
$ 3600/- Single User License
$ 4800/- Multi User License
$ 6800/- Corporate License

Paypal Certified Payment
Why To Choose Us:
  • Markets in over 100+ countries analyzed granularly
  • 35% of our total client are returning clients
  • 1000+ customers globally
  • 100+ paid data sources mined to bring cutting-edge insights
  • 24x5 availability - we are always there when you need us
  • "Free of Cost Report Customization" is available
  • Request a regional report at Best Price
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report

Impacts of COVID-19
COVID-19 Impact on the Single Nucleotide Polymorphism (SNP) Genotyping Market


Our Clients